Interleukin-6 functions in autoimmune encephalomyelitis: A study in gene-targeted mice

European Journal of Immunology

Volumn 28, Issue 5, 1998, Pages 1727-1737

  Mendel, Itzhack ^a   Katz, Anne ^a   Kozak, Natacha ^a   Ben Nun, Avraham ^a   Revel, Michel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Autoimmunity; Experimental autoimmune encephalomyelitis; Gene targeted mouse; IL 6; Multiple sclerosis

Indexed keywords

ENCEPHALITOGENIC PROTEIN; INTERLEUKIN 6;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; HISTOLOGY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MOUSE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; SPINAL CORD; T LYMPHOCYTE;

EID: 0031921636     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199805)28:05<1727::aid-immu1727>3.0.co;2-%23     Document Type: Article

References (37)

1. Kerlero de Rosbo, N., Milo, R., Lees, M. B., Burger, D., Bernard, C. C. A. and Ben-Nun, A., Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 1993. 92: 2602-2608.
2. Kerlero de Rosbo, N., Mendel, I. and Ben-Nun, A., Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 1995. 25: 985-993.
3. b mice: fine specificity and T cell receptor Vβ expression of encepnalitogenic T cells. Eur. J. Immunol. 1995. 25: 1951-1959.
4. b mice. Eur. J. Immunol. 1996. 26 2470-2479.
5. Lassmann, H. and Linington, C., The role of antibodies against myelin surface antigens in demyelination in chronic EAE: In: Crescenzi, G. S. (Ed.) A multidisciplinary approach to myelin diseases. Plenum Press, New York 1987, pp. 219-225.
6. Kerlero de Rosbo, N., Honegger, P., Lassmann, H. and Matthieu, J.-M., Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin oligodendrocyte glycoprotein. J. Neurochem. 1990. 55: 583-587.
7. Merril, J. E. and Benveniste, E. N., Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 1996. 19: 331-338.
8. Revel, M., Host defense against infections and inflammations: Role of multifunctional IL-6/IFN-β2 cytokine. Experientia 1989. 45: 549-557.
9. Kishimoto, T., Akira, S. and Taga, T., Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992. 258: 593-597.
10. Campbel, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B. and Mucke, L., Neurological disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc. Natl. Acad. Sci. USA 1993. 90: 10061-10065.
11. Brett, F. M., Mizisin, A. P., Powell, H. C. and Campbell, I. L., Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J. Neuropathol. Exp. Neurol. 1995. 54: 766-775.
12. Barres, B. A., Schmidt, R., Sendtner, M. and Raff, M. C., Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993. 118: 283-295.
13. Kahn, M. A. and De Vellis, J., Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia 1994. 12: 87-98.
14. Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T. and Kishimoto, T., Interleukin-6 triggers the association of its receptor with a possible signal transducer gp130. Cell 1989. 58: 573-581.
15. Novick, D., Shulman, L. M., Chen, L. and Revel, M., Enhancement of interleukin-6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibodies. Cytokine 1992. 4: 6-11.
16. Hirota, H., Kiyama, H., Kishimoto, T. and Taga, T., Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J. Exp. Med. 1996. 183: 2627-2634.
17. Rodriguez, M., Pavelko, K. DI., McKinney, C. W. and Leibowitz, J. L, Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J. Immunol. 1994. 153: 3811-3821.
18. Suzuki, Y., Rani, S., Liesenfeld, O., Kojima, T., Lim, S., Nguyen, T. A., Dalrymple, S. A., Murray, R. and Remington, J. S., Impaired resistance to the development of toxoplasmosis encephalitis in Interleukin-6 deficient mice. Infect. Immun. 1997. 65: 2339-2345.
19. Suzuki, Y., Yang, QI., Conley, F. K., Abrams, J. S. and Remington, J. S., Antibody against Interleukin-6 reduces inflammation and number of cysts in brains of mice with toxoplasmic encephalitis. Infect Immun. 1994. 62: 2773-2778.
20. Gijbels, K., Brocke, S., Abrams, J. S. and Steinman, L., Administration of neutralizing antibodies to Interleukin-6 reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1995. 1: 795-805.
21. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H. and Kohler, G., Impaired immune and acute-phase responses in interleukin-6 deficient mice. Nature 1994. 368: 339-342.
22. Ben-Nun, A. and Lando, Z., Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice. J. Immunol 1983. 130: 1205-1209.
23. Allison, J. P. and Krummel, M. F., The Yin and Yang of T cell costimulation. Science 1995. 270: 932-933.
24. Gong, J. H., Zhang, M., Modlin, R. L., Linsley, P. S., lyer, D., Lin, Y. and Barnes, P. F., Interleukin-10 downregulates mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect. Immun. 1996. 64: 913-918.
25. Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luni, W., van Hinsbergh, V., Sozzani, S., Bussolino, F., Poli, V., Ciliberto, G. and Mantovani, A., Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997. 6: 315-325.
26. Panitch, H. S. and Bever, C. T., Clinical trials of interferons in multiple sclerosis: what have we learned? J. Neuroimmunol. 1993. 46: 155-164.
27. Krakowski, M. and Owens, T., Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 1996. 26: 1641-1646.
28. Revel, M., Chebath, J., Mangelus, M., Harroch, S. and Moviglia, G. A. Antagonism of interferon beta on interferon gamma: inhibition of signal transduction in vitro and reduction of serum levels in multiple sclerosis patients. Multiple Sclerosis 1995. 1: S5-S11.
29. Aderka, D., Le, J. M. and Vilcek, J., IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured monocytes, U937 cells, and in mice. J. Immunol. 1989. 143: 3517-3523.
30. Barton, B. E. and Jackson, J. V., Protective role of interleukin-6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun. 1993. 61: 1496-1499.
31. Di Santo, E., Alonzi, T., Poli, V., Fattori, E., Toniatti, C., Sironi, M., Ricciardi-Castagnoli, P. and Ghezzi, P., Differential effects of IL-6 on systemic and central production of TNF: a study with IL-6 deficient mice. Cytokine 1997. 9: 300-306.
32. Frei, K., Malipero, U. V., Leist, T. P., Zinkernagel, R. M., Schwab, M. E. and Fontana, A., On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 1989. 19: 689-694.
33. Frei, K., Fredrikson, S., Fontana, A. and Link, H., Interleukin-6 is elevated in plasma in multiple sclerosis, J. Neuroimmunol. 1991. 31: 147-153.
34. Maimone, D., Guazzi, G. C. and Annunziata, P., IL-6 detection in multiple sclerosis brain. J. Neurol. Sci. 1997. 146: 59-65.
35. Savino, R., Ciapponi, L., Lahm, A., Demartis, A., Cabibbo, A., Toniatti, C., Delmastro, P., Altamura, S. and Ciliberto, G., Rational design of a receptor superantagonist of human interleukin-6. EMBO J. 1994. 13: 5863-5870.
36. Halimi, H., Eisenstein, M., Oh, J.-W., Revel, M. and Chebath, J., Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells. Eur. Cytokine Netw. 1995. 6: 135-143.
37. Kishomoto, T., Akira, S., Narazaki, M. and Taga, T., Interleukin-6 family of cytokines and gp130. Blood 1995. 86: 1234-1254.